Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06802965

Shanghai Atrial Fibrillation Registry

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
400,000 (estimated)
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Using the Shanghai Municipal Health Commission database and Shanghai Centers for Disease Control and Prevention database, patients with AF in Shanghai are included to construct the Shanghai AF registry to investigate clinical characteristics, treatment, and prognosis.

Detailed description

1. To determine the most suitable risk stratification model for Chinese AF population regarding stroke and major cardiovascular events, i.e. CHA2DS2-VASc, CHA2DS2-VASc-60, or CHA2DS2-VA scores. 2. To compare the clinical prognosis of patients with AF receiving the combined procedure of catheter ablation and left atrial appendage closure (LAAC), single catheter ablation, and single LAAC.

Conditions

Interventions

TypeNameDescription
PROCEDUREcatheter ablation, left atrial appendage closureCompare the clinical prognosis of patients with AF underwent the combined procedure of catheter ablation and left atrial appendage closure (LAAC), single catheter ablation and single LAAC.

Timeline

Start date
2025-01-01
Primary completion
2028-01-01
Completion
2030-01-01
First posted
2025-01-31
Last updated
2025-01-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06802965. Inclusion in this directory is not an endorsement.